Pesquisas alternativas:
daily companies » dairy companies (Expandir a Pesquisa), family companies (Expandir a Pesquisa), railway companies (Expandir a Pesquisa)
companies phase » companies case (Expandir a Pesquisa), companies past (Expandir a Pesquisa), companies choose (Expandir a Pesquisa)
tumors phase » tumors case (Expandir a Pesquisa), tumors based (Expandir a Pesquisa), tumors part (Expandir a Pesquisa)
tail tumors » tail tumor (Expandir a Pesquisa), nail tumors (Expandir a Pesquisa), gall tumors (Expandir a Pesquisa)
comps con » compost con (Expandir a Pesquisa), comps los (Expandir a Pesquisa)
con neto » con feto (Expandir a Pesquisa), con veto (Expandir a Pesquisa), con net (Expandir a Pesquisa)
l comps » m comps (Expandir a Pesquisa)
3 tail » h3 tail (Expandir a Pesquisa), 3 tails (Expandir a Pesquisa), _ tail (Expandir a Pesquisa)
daily companies » dairy companies (Expandir a Pesquisa), family companies (Expandir a Pesquisa), railway companies (Expandir a Pesquisa)
companies phase » companies case (Expandir a Pesquisa), companies past (Expandir a Pesquisa), companies choose (Expandir a Pesquisa)
tumors phase » tumors case (Expandir a Pesquisa), tumors based (Expandir a Pesquisa), tumors part (Expandir a Pesquisa)
tail tumors » tail tumor (Expandir a Pesquisa), nail tumors (Expandir a Pesquisa), gall tumors (Expandir a Pesquisa)
comps con » compost con (Expandir a Pesquisa), comps los (Expandir a Pesquisa)
con neto » con feto (Expandir a Pesquisa), con veto (Expandir a Pesquisa), con net (Expandir a Pesquisa)
l comps » m comps (Expandir a Pesquisa)
3 tail » h3 tail (Expandir a Pesquisa), 3 tails (Expandir a Pesquisa), _ tail (Expandir a Pesquisa)
1
Por Green, C A, Scarselli, E, Voysey, M, Capone, S, Vitelli, A, Nicosia, A, Cortese, R, Thompson, A J, Sande, C S, de Lara, Catherine, Klenerman, P, Pollard, A J
Publicado no BMJ Open (2015)
“... years test either a single dose of IM MVA-RSV, one of three combinations of IN or IM PanAd3-RSV prime...”Publicado no BMJ Open (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Komiya, Takefumi, Memmott, Regan M., Blumenthal, Gideon M., Bernstein, Wendy, Ballas, Marc S., De Chowdhury, Roopa, Chun, Guinevere, Peer, Cody J., Figg, William D., Liewehr, David J., Steinberg, Seth M., Giaccone, Giuseppe, Szabo, Eva, Kawabata, Shigeru, Tsurutani, Junji, Rajan, Arun, Dennis, Phillip A.
Publicado no Transl Lung Cancer Res (2019)
“...BACKGROUND: Single-agent pemetrexed is a treatment for recurrent non-squamous non-small cell lung...”Publicado no Transl Lung Cancer Res (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Bodin, T, García-Trabanino, R, Weiss, I, Jarquín, E, Glaser, J, Jakobsson, K, Lucas, R A I, Wesseling, C, Hogstedt, C, Wegman, D H
Publicado no Occup Environ Med (2016)
“... and with dehydration decreased. Individual daily production increased from 5.1 to a high of 7.3 tons/person/day...”Publicado no Occup Environ Med (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Castagnetti, Fausto, Breccia, Massimo, Gugliotta, Gabriele, Martino, Bruno, D’Adda, Mariella, Stagno, Fabio, Carella, Angelo Michele, Avanzini, Paolo, Tiribelli, Mario, Trabacchi, Elena, Visani, Giuseppe, Gobbi, Marco, Salvucci, Marzia, Levato, Luciano, Binotto, Gianni, Capalbo, Silvana Franca, Bochicchio, Maria Teresa, Soverini, Simona, Cavo, Michele, Martinelli, Giovanni, Alimena, Giuliana, Pane, Fabrizio, Saglio, Giuseppe, Rosti, Gianantonio, Baccarani, Michele
Publicado no Haematologica (2016)
“... leukemia patients in early chronic phase. A deep molecular response was achieved in 46% (MR(4.0)) and 17...”Publicado no Haematologica (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Edwards, Christopher J, Blanco, Francisco J, Crowley, Jeffrey, Birbara, Charles A, Jaworski, Janusz, Aelion, Jacob, Stevens, Randall M, Vessey, Adele, Zhan, Xiaojiang, Bird, Paul
Publicado no Ann Rheum Dis (2016)
“... area involvement ≥3%, significantly more apremilast 30 mg twice daily patients achieved 50% reduction...”Publicado no Ann Rheum Dis (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Dragnev, Konstantin H., Whyman, Jeremy D., Hahn, Cynthia K., Kebbekus, Peter E., Kokko, Sarah F., Bhatt, Sunil M., Rigas, James R.
Publicado no J Thorac Dis (2018)
“... with chemotherapy. This phase I/II study evaluates the tolerability and activity of a rexinoid, bexarotene, combined...”Publicado no J Thorac Dis (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Williams, Michael A, McKay, Gareth J, Chakravarthy, Usha
Publicado no Cochrane Database Syst Rev (2014)
“... MEDLINE In‐Process and Other Non‐Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946...”Publicado no Cochrane Database Syst Rev (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Farrell, M. Ryan, Ziegelmann, Matthew J., Levine, Laurence A.
Publicado no Transl Androl Urol (2020)
“... or for those with less severe deformity who elect to avoid surgery, a variety of non-surgical treatment options...”Publicado no Transl Androl Urol (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Govender, Roganie, Smith, Christina H, Gardner, Benjamin, Barratt, Helen, Taylor, Stuart A
Publicado no BMJ Open (2017)
“...-treatment morbidity as a result of dysphagia, which affects daily functioning and quality of life (QOL...”Publicado no BMJ Open (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Njike, Valentine Y, Ayettey, Rockiy G, Rajebi, Hamid, Treu, Judith A, Katz, David L
Publicado no BMJ Open Diabetes Res Care (2016)
“...-week washout periods. For the egg inclusion phase, participants received advice from a dietitian on how...”Publicado no BMJ Open Diabetes Res Care (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Cao, Huijuan, Yang, Guoyan, Wang, Yuyi, Liu, Jian Ping, Smith, Caroline A, Luo, Hui, Liu, Yueming
Publicado no Cochrane Database Syst Rev (2015)
“... tree oil. A pharmaceutical company funded one trial; the other trials did not report their funding...”Publicado no Cochrane Database Syst Rev (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Frank, Daniel, Jumonville, Alcee, LoConte, Noelle K, Schelman, William R, Mulkerin, Daniel, Lubner, Sam, Richter, Katie, Winterle, Natalie, Wims, Mary Beth, Dietrich, Leah, Winkler, J. Mitchell, Volk, Michael, Kim, KyungMann, Holen, Kyle D.
Publicado em 2012
“..., non-randomized phase II study of lapatinib 1,250 mg orally daily and capecitabine 2,000 mg/m(2...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Dorkin, Henry L, Staab, Doris, Operschall, Elisabeth, Alder, Jeff, Criollo, Margarita
Publicado no BMJ Open Respir Res (2015)
“...BACKGROUND: Treatment of infective bronchitis involving Pseudomonas aeruginosa is a cornerstone...”Publicado no BMJ Open Respir Res (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Dahl, Ronald, Calverley, Peter M A, Anzueto, Antonio, Metzdorf, Norbert, Fowler, Andy, Mueller, Achim, Wise, Robert, Dusser, Daniel
Publicado no BMJ Open (2015)
“... 18 µg (HH18) prior to study entry, to evaluate whether there was a difference in risk for patients...”Publicado no BMJ Open (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Peters, Esther, Mehta, Ravindra L, Murray, Patrick T, Hummel, Jürgen, Joannidis, Michael, Kellum, John A, Arend, Jacques, Pickkers, Peter
Publicado no BMJ Open (2016)
“... assigned to receive either placebo (n=30) or 1 of 3 different doses of recAP (n=30 per group) once daily...”Publicado no BMJ Open (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
“... by the AS programme. The control period (phase 0) lasted 3 months. Thereafter, AS was implemented in each of four...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Azuma, Koichi, Hirashima, Tomonori, Yamamoto, Nobuyuki, Okamoto, Isamu, Takahashi, Toshiaki, Nishio, Makoto, Hirata, Taizo, Kubota, Kaoru, Kasahara, Kazuo, Hida, Toyoaki, Yoshioka, Hiroshige, Nakanishi, Kaoru, Akinaga, Shiro, Nishio, Kazuto, Mitsudomi, Tetsuya, Nakagawa, Kazuhiko
Publicado no ESMO Open (2016)
“... patients with NSCLC with acquired resistance to EGFR-TKIs, who were orally administered a daily combination...”Publicado no ESMO Open (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por van der Heijde, Désirée, Deodhar, Atul, Wei, James C, Drescher, Edit, Fleishaker, Dona, Hendrikx, Thijs, Li, David, Menon, Sujatha, Kanik, Keith S
Publicado no Ann Rheum Dis (2017)
“... was monitored. RESULTS: Emax model analysis of the primary endpoint predicted a tofacitinib 10 mg twice daily...”Publicado no Ann Rheum Dis (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Cluver, Catherine A, Walker, Susan P, Mol, Ben W, Theron, Gerard B, Hall, David R, Hiscock, Richard, Hannan, N, Tong, S
Publicado no BMJ Open (2015)
“... and oxidative stress. METHODS AND ANALYSIS: We propose undertaking a phase II, double blind, randomised...”Publicado no BMJ Open (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Lancaster, Lisa, Albera, Carlo, Bradford, Williamson Z, Costabel, Ulrich, du Bois, Roland M, Fagan, Elizabeth A, Fishman, Robert S, Glaspole, Ian, Glassberg, Marilyn K, King, Talmadge E, Lederer, David J, Lin, Zhengning, Nathan, Steven D, Pereira, Carlos A, Swigris, Jeffrey J, Valeyre, Dominique, Noble, Paul W
Publicado no BMJ Open Respir Res (2016)
“... treated with pirfenidone in the three multinational Phase 3 studies (CAPACITY (studies 004 and 006...”Publicado no BMJ Open Respir Res (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo